Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.BRCA mutations do not impact progression-free survival in early ovarian cancer. However, BRCA-mutated patients show a better prognosis after relapse, with secondary cytoreductive surgery and PARPi maintenance improving post-recurrence survival.
Area Of Science
- Oncology
- Genetics
- Gynecologic Oncology
Background
- Early ovarian cancer (eOC) prognosis is critical for patient outcomes.
- The role of BRCA1/2 mutations in high-grade serous (HGS)-eOC requires further clarification, particularly concerning survival after recurrence.
Purpose Of The Study
- To investigate the impact of BRCA1/2 mutations on prognosis in early-stage ovarian cancer (FIGO stages I-II).
- To assess the influence of BRCA status on survival outcomes, including progression-free survival (PFS), overall survival (OS), and post-recurrence survival (PRS).
Main Methods
- A multicenter retrospective study analyzed clinical and survival data from 191 HGS-eOC patients.
- Patients were stratified based on BRCA mutation status: BRCA-mutated (BRCAmut) versus BRCA wild-type (BRCAwt).
- Statistical analyses, including multivariate analysis, were performed to identify prognostic factors for PFS, OS, and PRS.
Main Results
- No significant difference in PFS was observed between BRCAmut and BRCAwt groups.
- BRCAmut patients demonstrated longer OS, although not statistically significant in multivariate analysis.
- Stage I patients had significantly improved PFS compared to stage II patients, irrespective of BRCA status.
- Post-recurrence survival (PRS) was significantly improved in the BRCAmut population.
- Secondary cytoreductive surgery and PARPi maintenance at recurrence were strong predictors of longer PRS.
Conclusions
- BRCA status is not a prognostic factor for progression-free survival in early ovarian cancer.
- BRCA mutations are associated with a potentially better prognosis after relapse in early-stage ovarian cancer patients.
- Treatment strategies such as secondary cytoreductive surgery and PARPi maintenance are crucial for improving outcomes in recurrent ovarian cancer.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...